Literature DB >> 21738257

Hepatotoxicity following cyclophosphamide treatment in a patient with MPO-ANCA vasculitis.

M Martínez-Gabarrón, R Enríquez, A E Sirvent, M García-Sepulcre, I Millán, F Amorós.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21738257     DOI: 10.3265/Nefrologia.pre2011.May.10917

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  6 in total

1.  Liver involvement in ANCA-associated vasculitis.

Authors:  Peter Willeke; Bernhard Schlüter; Armend Limani; Heidemarie Becker; Heiko Schotte
Journal:  Clin Rheumatol       Date:  2015-01-30       Impact factor: 2.980

2.  Protective effect of centella triterpene saponins against cyclophosphamide-induced immune and hepatic system dysfunction in rats: its possible mechanisms of action.

Authors:  Pragathi Duggina; Chandra Mouli Kalla; Seshadri Reddy Varikasuvu; Suman Bukke; Vijaya Tartte
Journal:  J Physiol Biochem       Date:  2015-07-14       Impact factor: 4.158

3.  18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation.

Authors:  Ayman M Mahmoud; Hussein S Al Dera
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

Review 4.  Cyclophosphamide-induced severe acute hepatitis in a rheumatic disease: case-based review.

Authors:  Döndü Üsküdar Cansu; Erkin Öztaş; Evrim Yilmaz; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2018-10-30       Impact factor: 2.631

5.  Low-dose cyclophosphamide-induced acute hepatotoxicity.

Authors:  S Ravih Subramaniam; Rizna Abdul Cader; Rozita Mohd; Kong Wei Yen; Halim Abdul Ghafor
Journal:  Am J Case Rep       Date:  2013-09-04

6.  Peroxisome Proliferator Activator Receptor (PPAR)- γ Ligand, but Not PPAR- α , Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver.

Authors:  Azza A K El-Sheikh; Rehab A Rifaai
Journal:  PPAR Res       Date:  2014-04-02       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.